Circulation

Vol. 152, Issue Suppl_3 Issue Suppl_3 2025
4221
Articles

Articles in this Issue

Abstract 4367002: The Starved Heart: Pericarditis in Extreme Anorexia Nervosa

Mohamad Mansour, Obaid Haque, Aseed Mestarihi Nov 04, 2025 10.1161/circ.152.suppl_3.4367002

Background: Anorexia nervosa (AN) is a psychiatric disorder defined by restrictive eating, fear of weight gain, and distorted body image, with a lifetime prevalence of ~4% among fe...

Abstract 4364919: Association of Antiphospholipid Syndrome with Infective Endocarditis and Staphylococcal Sepsis: A U.S. Nationwide Inpatient Sample Analysis

Bahy Abofrekha, Jessica Schwartz, Chloe Lahoud et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4364919

Background: Antiphospholipid syndrome (APS) predisposes patients to thrombosis and cardiac valve lesions (e.g., Libman-Sacks endocarditis). These vegetations, though sterile, may s...

Abstract 4370881: Elevated Pulmonary Artery Wedge Pressure at Transcatheter Pulmonary Valve Replacement: Clinical and Prognostic Associations

Keerthika Vijayakumar, Renato Hortegal, Rawan Amir et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4370881

Background: Heart failure (HF) is the leading cause of mortality in adults with congenital heart disease (CHD) after transcatheter pulmonary valve replacement (TPVR), likely due to...

Abstract 4370739: Integrative analysis of MoTrPAC and LINCS transcriptomes identifies cardiovascular-relevant exercise-mimetic drugs

Pauline Brochet, David Jimenez-Morales, Malene Lindholm et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4370739

Introduction: Exercise is a cornerstone of cardiovascular health, yet not all individuals can engage in sufficient physical activity. Identifying pharmacological agents that mimic...

Abstract 4371491: <i>Clinical and Demographic Predictors of Surgical Intervention in a Multidisciplinary Lymphedema Program: A Vascular Medicine Perspective</i>

Alexandra Medline, Firas Hentati, Prabhu Sasankan et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4371491

Introduction: Lymphedema is increasingly recognized as a condition best served within multidisciplinary care models. Identifying patient characteristics associated with surgical co...

Abstract 4367453: External Validation of an AI-ECG algorithm for Occlusive Myocardial Infarction Detection in a General Chest Pain Population

Rui Qi Ji, Nathan Riek, Dillon Dzikowicz et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4367453

Background: Nearly one-third of patients with Acute Coronary Syndrome have an acute coronary occlusion without diagnostic ST elevations (STE) that often goes unrecognized, leading...

Abstract 4365806: <i>Patient and Procedural Characteristics Associated with GERD and Chest Pain After Atrial Fibrillation Ablation with Esophageal Cooling: Results from the Multicenter EVERCOOL AF Registry.</i>

Joshua Silverstein, George Shaw, Huy Phan et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4365806

Background: Gastroesophageal reflux disease (GERD) and chest pain are common complications following catheter ablation for atrial fibrillation (AF), often attributed to esophageal...

Abstract 4366534: Mortality risk and procedural complications with general anesthesia compared to monitored anesthesia care in percutaneous LAAo: A Propensity-Matched Real-World Analysis

Zainab Zaib Khan, Mustafa Shehzad, Ahmed Sajid et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4366534

Introduction: During percutaneous LAAo, intraprocedural guidance with TEE and fluoroscopy is the standard of care. While general anesthesia with intubation (GA) has historically be...

Abstract 4364982: Serum GUDCA Alleviates Cardiac Injury in Acute Myocardial Infarction by Promoting Regulatory T Cell Differentiation

Jiayu Li, Hui Chen, Yang Xiang et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4364982

Background: Regulatory T cells (Tregs) exert protective effects following acute myocardial infarction (AMI), yet their levels decline rapidly after injury. Although serum metabolit...

Abstract 4367271: Sex and Racial Disparities in Atherosclerotic Heart Disease Mortality Among Older Adults in the United States: A CDC WONDER Database Analysis (1999–2020)

Fatima Aman Makda, Ifrah Ansari, Jazza Aamir et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4367271

Background: Atherosclerotic heart disease (ASHD) remains a leading cause of death among older adults in the United States. However, disparities in ASHD-related mortality by sex and...

Abstract 4365077: Subclinical Inflammatory Biomarker Profiles and Associations with Future Chronic Inflammatory-Related Disease and Cardiovascular Disease in the Multi-Ethnic Study of Atherosclerosis

Evan Manning, David Jacobs, Daniel Duprez Nov 04, 2025 10.1161/circ.152.suppl_3.4365077

Background: Inflammation is associated with cardiovascular diseases (CVD). We previously described Chronic Inflammatory-Related Disease (ChrIRD), a composite of non-cardiovascular,...

Abstract 4339180: The Proof is in the Pillbox: An Elusive Case of Cardiomyopathy

grace hagan, Teodora Donisan, Patricia Carey et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4339180

A 63-year-old female with mixed connective tissue disease on long-term immunosuppression (prednisone, azathioprine, hydroxychloroquine (HCQ)) was referred to a tertiary care center for evaluation of p...

Abstract 4366937: Cavo-Tricuspid Isthmus Ablation in Atrial Flutter with Uncorrected Ebstein’s Anomaly: A Scoping Review

Shubhika Jain, Samarth Goyal, Prerana Ramesh et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4366937

Background: Ebstein’s anomaly (EA) is a rare congenital heart defect characterized by apical displacement and abnormal development of the tricuspid valve, resulting in right atrial...

Abstract 4342725: Prognostic value of aldosterone for incident cardiovascular disease and mortality in the population-based Gutenberg Health Study

Silav Zeid, Rieke Baumkoetter, Alexander Gieswinkel et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4342725

Background: Dysregulated aldosterone is a modulator for the development and progression of cardio-renal-metabolic disease. Aim: This study aime...

Abstract 4368215: Long-Term Clinical Outcomes between P2Y12 Inhibitor Monotherapy and Prolonged Dual Antiplatelet Therapy in Patients with Poly-vascular Disease: Sub-study of the SMART-CHOICE Randomized Trial

Tae Kyung Yoo, Ki Hong Choi, Jong-Young Lee et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4368215

Background: The optimal antiplatelet treatment strategy for poly-vascular disease after percutaneous coronary intervention (PCI) is uncertain....

Abstract 4345579: Once Weekly Utreglutide (GL0034), a Glucagon-like Peptide-1 Receptor Agonist Reduces Liver Fat Content along with Blood Pressure in Post-menopausal Females with Obesity: A Phase 1a/2b Study

Rajamannar Thennati, Vinod Burade, Muthukumaran Natarajan et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4345579

Background: Utreglutide (GL0034, UTG), a novel, once weekly glucagon-like peptide-1 receptor agonist (GLP-1RA), demonstrated clinically relevant reductions of systolic and diastoli...

Abstract 4368357: Comparative 2 Year Outcomes of Carvedilol Versus Metoprolol Succinate initiation in Heart failure with reduced ejection fraction Patients with End-Stage Renal Disease on Dialysis: A Propensity- Matched analysis

Efeturi Okorigba, Abdulraheem Hassan, Samuel Mensah et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4368357

Background: Heart failure with reduced ejection fraction (HFrEF) in patients with end-stage renal disease (ESRD) on dialysis is associated with high morbidity and mortality. it rem...

Abstract 4362320: Relationship between the Cardiovascular-Kidney-Metabolic Syndrome Stages and Cardiovascular Adverse Outcomes in the Beijing Community Population

Shengcong Liu, Kaiyin Li, Jia Jia et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4362320

Background: Among Asian populations, there have been limited reports on the impact of cardiovascular-kidney-metabolic (CKM) syndrome stages on adverse cardiovascular outcomes. This...

Abstract 4360678: Intravenous Administration of Muse Cells Promotes Long-Lasting Functional Recovery in a Rat Model of Spinal Cord Ischemic Injury

Masayuki Otani, Yoshihiro Kushida, Yasumasa Kuroda et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4360678

Introduction: Spinal cord ischemic injury (SCII) is a devastating complication of aortic surgery that often leads to irreversible motor dysfunction. Despite its clinical severity,...

Abstract 4357798: Risk assessment in primary prevention: plaque matters most

Warren Skoza, Dylan Taylor, Belen de Cortes Oliva Pellicer et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4357798

Background: Cardiovascular disease (CVD) risk stratification in primary prevention involves risk factor-based calculators. Subclinical atherosclerosis (SA) disease burden represent...

Abstract 4342945: The Diagnosis of Vasovagal Syncope Requires an Extended Duration of the Head-Up Tilt Table Test

Mohab Eid, Diego Ramonfaur, Bianca Honnekeri et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4342945

Background: Vasovagal syncope (VVS) is a type of reflex syncope in which transient loss of consciousness is caused by reflex vasodepression and/or cardioinhibition leading to cereb...

Abstract 4370383: Cannabidiol alleviates fibrosis through AGE-RAGE axis inhibition in a Non-Ischemic Mouse Model of Heart Failure

Abraham Mendez-Fernandez, Muthu Kumar Krishnamoorthi, Omar Lozano et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4370383

Background: Cannabidiol has been shown recently to improve cardiac function in mouse models of heart failure with a potential mechanism through influencing mitochondrial bioenerget...

Abstract 4366521: PREVENT Outperforms Pool Cohort Equation in Predicting 10-Year Cardiovascular Risk in a National Cohort

Jay Patel, Mohammed Ruzieh Nov 04, 2025 10.1161/circ.152.suppl_3.4366521

Introduction: PREVENT is a new prediction tool used for cardiovascular risk management. The purpose of this study was to investigate whether the PREVENT risk score is more accurate...

Abstract 4361884: Improvement in Echocardiographic Measures of Diastolic Function Reflects Improved Exercise Performance in Obstructive Hypertrophic Cardiomyopathy: Insights From the SEQUOIA-HCM Trial

Henri Lu, Nicole Bart, Brian Claggett et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4361884

Background: A hallmark feature of obstructive hypertrophic cardiomyopathy (oHCM) is impaired exercise capacity, which impacts quality of life and is a determinant of clinical outco...

Abstract 4350460: COVID-induced TNF receptor-associated periodic syndrome: a case of refractory microvascular angina resolved with anti-interleukin-1 therapy by multimodality imaging

Alyssa Chang, Joshua Levenson Nov 04, 2025 10.1161/circ.152.suppl_3.4350460

Background: Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory condition associated with recurrent episodes of fever, chest pain,...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page